首页> 外文期刊>Haematologica >Mutations of AML1 in non-M0 acute myeloid leukemia: six novel mutations and a high incidence of cooperative events in a South-east Asian population | Haematologica
【24h】

Mutations of AML1 in non-M0 acute myeloid leukemia: six novel mutations and a high incidence of cooperative events in a South-east Asian population | Haematologica

机译:非M0急性髓细胞性白血病中AML1的突变:东南亚人群中的六个新突变和合作事件的发生率很高|血液学

获取原文
           

摘要

Point mutations of AML1 are uncommon and predominantly reported in a rare minimally differentiated acute myeloid leukemia (M0 AML). Few data exist regarding the frequency of AML1 mutations in non-M0 cases. We screened 284 consecutive adult Thai patients with de novo AML and found that 3.9% had AML1 mutations. The highest incidence occurred in M6. Six novel mutations were uniquely identified in non-M0 cases. Sixty-four percent of the non-M0 patients with AML1 mutations had coexisting genetic abnormalities including FLT3 mutation in 36%. Our study provides evidence to support the model of multiple co-operating events, which could also be critical in the development of leukemia in non-M0 AML patients with mutated AML1. The prognostic significance of these novel mutations remains to be determined.
机译:AML1的点突变并不常见,并且主要在罕见的最小分化急性髓性白血病(M0 AML)中报告。在非M0病例中,很少有关于AML1突变频率的数据。我们筛选了284名连续的泰国成年AML成人患者,发现3.9%的患者患有AML1突变。发生率最高的地区为M6。在非M0病例中,独特地鉴定出六个新突变。 AML1突变的非M0患者中有64%并存遗传异常,包括36%的FLT3突变。我们的研究提供了支持多种合作事件模型的证据,这对于非AML突变AML1的非M0 AML患者的白血病发展也可能至关重要。这些新突变的预后意义尚待确定。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号